NXL Nexalin Technology
- 0.8992
- -0.4811-34.85%
- 0.7911
- -0.1081-12.02%
Nexalin Technology News
12 Health Care Stocks Moving In Friday's Intraday Session
GainersCyclerion Therapeutics (NASDAQ:CYCN) shares moved upwards by 37.4% to $2.9 during Friday's regular session. The market value of their outstanding shares is at $7.2 million. CNS Pharma (NASDAQ:C
Nexalin Technology Files to Offer Up to $7 Million in Common Stock >NXL
Nexalin Technology Files to Offer Up to $7 Million in Common Stock >NXL
Nexalin Technology Falls 33%
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
U.S. stocks traded mostly lower this morning, with the Dow Jones index dipping more than 200 points on Friday.Following the market opening Friday, the Dow traded down 0.60% to 38,415.98 while the NASD
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Adobe Inc. (NASDAQ:ADBE) rose sharply in today's pre-market trading following better-than-expected second-quarter earnings and strong guidance.Adobe reported second-quarter revenue of $5.31
Nexalin Tech (NXL) Sees Wild Stock Swings Amid Regulatory Approval
Nexalin Technology, Inc. (NASDAQ: NXL) experienced a remarkable surge on Thursday, with its stock price rocketing upwards by 121%, more than doubling from $0.62 to $1.38. This extraordinary rise was fueled by significant investor interest following the company's announcement of regulatory approval for its second-generation (Gen-2) 15 milliamp (mA) neurostimulation device by the Brazilian Health ...
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersVaxart (NASDAQ:VXRT) shares increased by 146.7% to $1.85 during Thursday's after-market session. The market value of their outstanding shares is at $327.1 million. Venus Concept (NASDAQ:VERO) s
Express News | Nexalin Technology Announces Regulatory Approval Of Gen-2 15mA Neurostimulation Device By Brazilian Health Regulatory Agency
Express News | Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 Ma Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
HOUSTON, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) announced today that it will be participating in the Spring MicroCap Rodeo Conference, that will
Express News | Nexalin Technology Reports FDA Feedback And Reached Consensus On Nexalin's Design For Planned Anxiety And Insomnia Clinical Studies Of Its Gen-3 HALO Clarity Headset Device
Express News | Nexalin Technology Inc: After Studies Are Completed and Evaluated, Nexalin Plans to Submit a De Novo Request Application for Halo to FDA
Express News | Nexalin Technology Inc - Clinical Studies in Anxiety and Insomnia Expected to Commence in Q3 of 2024
Express News | FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of Its Gen-3 Halo Clarity™ Headset Device
Why American Eagle Outfitters Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of American Eagle Outfitters, Inc. (NYSE:AEO) fell during Thursday's session following first-quarter results.American Eagle Outfitters reported adjusted earnings of 17 cents per share and quart
Why Pure Storage Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Pure Storage, Inc. (NYSE:PSTG) rose sharply in today's pre-market trading following better-than-expected first-quarter financial results.Pure Storage reported quarterly earnings of 32 cents
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersCue Health (NASDAQ:HLTH) stock moved upwards by 44.2% to $0.08 during Thursday's pre-market session. The market value of their outstanding shares is at $12.5 million. OneMedNet (NASDAQ:ONMD) st
Express News | Nexalin Technology Inc Files for Common Stock Offering of up to $7.0 Mln - SEC Filing
Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
HOUSTON, TX, May 22, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) is pleased to announce its new division, Nexalin America, has been selected t
Nexalin Technology First Quarter 2024 Earnings: US$0.14 Loss per Share (Vs US$0.10 Loss in 1Q 2023)
Analysis
Price Target
No Data
